6-Bromo-3-methyl-1H-pyrido[2,3-b][1,4]oxazin-2(3H)-one, 98%, 250mg

1,4-oxazepan-5-one, 98.0%, 5g

2-Methoxy-6-(trifluoromethyl)aniline, 95.0%, 250mg

2-Phenyloxazole-4-carbaldehyde, 95.0%, 100mg

GC capillary column ROTI®Cap-1701 MS, 60 m, 0.25 mm, 0.25 µm, 1 Piece(s)

3-Nitrobenzofuran-5-ol, 97%, 5g

2-(2,4-Dimethoxybenzoyl)-3-methylpyridine, 97.0%, 1g

1-(5-chloro-2-methoxyphenyl)-3-(ethoxycarbonyl)-5-methyl-4,5-dihydro-1H-pyrazole-5-carboxylic acid, 95.0%, 1g

(S)-N-((R)-3,3-Dimethylbutan-2-yl)-3,3-dimethyl-2-(((1-methyl-1H-imidazol-2-yl)methyl)amino)butanamide, 97%, 25mg

3-Chloro-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one, 95.0%, 10g

Spiro[indene-2,4'-piperidin]-1(3H)-one hydrochloride, 95.0%, 100mg

1-Fluoro-4-(methylsulfinyl)benzene, 95+%, 5g

6-(TRIFLUOROMETHYL)-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-2-AMINE, 95.0%, 250mg